MA_0211 retweeted
আরশোলাদের ঠেকাতে দিল্লির সুন্দর রাস্তাকেই নোংরা করতে হচ্ছে!😃😂 এমন অভিনব বুদ্ধি কার মাথা থেকে বেরোল, সেটা জানার কৌতূহল হচ্ছে! 🤔🤣
প্রতিবাদ ঠেকাতে গিয়ে যদি রাস্তারই এই অবস্থা হয়, তাহলে এদের জ্ঞান-বুদ্ধি নিয়ে প্রশ্ন ওঠাটাই স্বাভাবিক!😊🙄
MA_0211 retweeted
JD Vance describes HIB professionals as “indentured servants”.
That’s an emotive word to use - given India’s history with indenture during the British Empire.
Vice President JD Vance breaks down the data:
"If you are working as an H-1B visa in the United States of America, you’re earning $20,000 less than an American citizen hired in the same position. If you were brought in by one of these foreign outsourcing firms, you’re making $48,000 less than an American citizen in a similar position. So I’m sure that everybody here understands the game that is being played. You bring in indentured servants from outside the country, you lay off American workers and, if you’re a corporation, you make a ton of money by under cutting the wages of American workers, replacing them with people who frankly shouldn’t be in the United States of America to begin with."
MA_0211 retweeted
Government of India restricted @abhijeet_dipke’s video on X almost immediately after it was posted.
This is the video the Government of India doesn’t want you to see.
teapawt.org/abhijeet_dipke/status/…
This quoted post is unavailable.
MA_0211 retweeted
Ashoka University criticised for dissociating itself from professor’s paper on election manipulation scroll.in/article/1053658/as… via @scroll_in
MA_0211 retweeted
#JustIn | Laurus Labs to buy 7.24% additional stake in #Immunoact for Rs 80 crore; company's stake in Immunoact to increase to 33.86%
MA_0211 retweeted
“We will multiply”… – at Merton, London
A new symbol of resistance -This is in memory of Hadis Najafi, an Iran protester seen in a widely shared video tying her hair back before confronting security forces. Hadis was killed. This person wrote:"We will multiply." (Video by @shire_khar) #حدیث_نجفی #مهسا_امینی #MahsaAmini
MA_0211 retweeted
Coming Soon!
@LaurusLabs's first rare disease product.
#WilsonsDisease #Trientine #RareDisease #MadeInIndia #MadeForIndia #lauruslabs #TrientineCapsule
MA_0211 retweeted
Homage to #FrontierGandhi on his 131st birth anniversary. Khan Abdul Ghaffar Khan was a true devotee of #MahatmaGandhi in thought, word and deed, and stood like a rock to prevent Partition of India, a cause for which he even surpassed the #Mahatma. – at New Delhi, India
MA_0211 retweeted
"Congratulations, PM Narendra Modi, the scientists, healthworkers & people of India, on your efforts to protect the vulnerable populations from COVID19 and achieve vaccine equity targets," tweets Tedros A. Ghebreyesus, Director-General of the World Health Organization
(file pic)
MA_0211 retweeted
Replying to @DrTamilisai4BJP @PMOIndia @rashtrapatibhvn @HMOIndia @santoshgangwar @drharshvardhan @PIB_India @PTI_News @ani_digital @DDNewslive @LabourMinistry
Please talk about degree final year students Exams and BTech final year students Exams and save Students future madam.please reduce the semester exams papers of Osmania University Exams madam .
By/
Banavath Ravinder Naik Telangana students committee state vice President
MA_0211 retweeted
#4QWithCNBCTV18 | Laurus Labs posted good Q4 results & all segments saw growth. @CEOLaurusLabs, Satyanarayana Chava says that co has an internal revenue target of $1 bn by FY23. Speaking to @latha_venkatesh & @SurabhiUpadhyay, he adds that biotech biz will add to growth from FY23
MA_0211 retweeted
Replying to @TheLancetInfDis
Good stuff but the PII study on @biorxivpreprint shows the Th1 cytokine profile of BBV152 is dominated by TNF-alpha - to be fair, this appears to be the case with all approved vaccines. Why's no one calling out TNF-alpha & its pro-inflammatory status? (despite being Th1 Cytokine) – at Hayathnagar, India
MA_0211 retweeted
NEW—Trump’s FDA & Gilead had **IGNORED** the world’s largest Remdesivir #COVID19 trial when FDA rushed its approval. @WHO is visibly irritated that it sent SOLIDARITY results (*zero* Remdesivir benefit) to Gilead on Sept 23 (full paper 28th), but FDA approved it anyway Oct 22nd!
World Health Organization: @US_FDA approval of Remdesivir for in-hospital COVID patients > 12 years old ignored world's biggest clinical trial data which showed no improvement in survival, progression to ventilation, or hospital discharge. @GileadSciences didn't present the data.
MA_0211 retweeted
Yes! Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study - ScienceDirect sciencedirect.com/science/ar…
MA_0211 retweeted
Let’s end this fraud!! The king has no clothes and HCQ works again!!Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants - ScienceDirect sciencedirect.com/science/ar…
MA_0211 retweeted
Even Baylor Scott White (Dallas) sees value #HCQ
MA_0211 retweeted
#Science says use #HCQ early to end pandemic, acc to @Yale MD, PhD Harvey Risch: “I believe this misbegotten episode re HCQ will be studied by sociologists as a classic example of how extra-scientific factors overrode clear-cut medical evidence.” newsweek.com/key-defeating-c…
MA_0211 retweeted
When Hindu Muslim didn’t work, now attempts being made to turn horrific Palghar lynching into left v right! The local MLA is CPIM and the village where incident took place has a BJP sarpanch! So stop playing ugly politics with a crime and deliver justice to sadhus! #Palghar
MA_0211 retweeted
Replying to @Mohansinha
Stop the trolling you morons!! Do you have a sense of the magnitude of the problem #COVID19 is? If we slip, 10% of our nation could be effected.
If you got it atleast now, stop being the #trolldogs of your master and focus on saving a few lives and let others do too.





























